Showing results (181-190 of 5,109) with videos related to
Sort By:
Pageof 511
Vox Sanguinis|December 9, 2004
The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patientsM-D Levin, B van der Holt, J C de Veld, et al.Vox Sanguinis|January 1, 1992
Quantitation of the human component C4: definition of C4 Q0 alleles and C4A duplicationsV Rebmann, I Doxiadis, B S Kubens, et al.Vox Sanguinis|January 1, 1992
Aluminum content of source plasma and sodium citrate anticoagulantJ C May, T C Rains, L J Yu, et al.Vox Sanguinis|January 1, 1992
First autoclave-sterilized platelet-additive solution containing glucose with a physiological pH for the preparation of plasma-poor platelet concentratesT Shimizu, K Shibata, S KoraVox Sanguinis|March 17, 2004
Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIIIP R Foster, B D Griffin, C Bienek, et al.Vox Sanguinis|March 17, 2004
In vitro study of a triple-secured von Willebrand factor concentrateC Mazurier, M Poulle, B Samor, et al.Vox Sanguinis|March 17, 2004
Influence of cell-free DNA in plasma on real-time polymerase chain reaction for determination of residual leucocytes in platelet concentratesM J Dijkstra-Tiekstra, R N I Pietersz, H W Reesink, et al.Vox Sanguinis|March 17, 2004
Weakened expression of 'e' owing to concomitant occurrence of Cys16 and Val245 (VS antigen)A Rodrigues, M Rios, F F Costa, et al.Vox Sanguinis|July 21, 2004
Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived productsK M Remington, S R Trejo, G Buczynski, et al.Vox Sanguinis|July 21, 2004
The in vitro quality of washed, prestorage leucocyte-depleted red blood cell concentratesV Weisbach, W Riego, E Strasser, et al.Pageof 511